Skip to ContentSkip to Navigation
Practical matters How to find us prof. dr. W. (Wim) Timens

Publications

A proteomics approach to identify COPD-related changes in lung fibroblasts

Optimalisatie van de zorgketen moleculaire diagnostiek bij niet-kleincellig longcarcinoom in Noord-Nederland

Smoking induces shifts in cellular composition and transcriptome within the bronchial mucus barrier

Targeted epigenetic silencing of UCHL1 expression suppresses collagen-1 production in human lung epithelial cells

Th2 high and mast cell gene signatures are associated with corticosteroid sensitivity in COPD

The additional diagnostic value of virtual bronchoscopy navigation in patients with pulmonary nodules: The NAVIGATOR study

Therapeutic drug monitoring guided dosing versus standard dosing of alectinib in advanced ALK positive non-small cell lung cancer patients: Study protocol for an international, multicenter phase IV randomized controlled trial (ADAPT ALEC)

3D Fibrotic Lung Extracellular Matrix Hydrogels Trigger Pro-Fibrotic Responses in Primary Lung Fibroblasts

Actionability of on-target ALK Resistance Mutations in Patients With Non-Small Cell Lung Cancer: Local Experience and Review of the Literature

Airflow limitation increases lung cancer risk in smokers: the Lifelines cohort study

Read more

Press/media

AI als multifocale bril van de patholoog

Longkanker: welke vorm heb ik?

Covid2019: ACE2-receptor speelde ook grote rol bij SARS.

Revival van de Dutch Hypothesis, in geïndividualiseerde vorm.

Pathologisch onderzoek essentieel voor kankerdiagnose

Kankercellen onder de loep

Zien welke kanker het is

PD-L1 kleuring vereist bij eerstelijnsbehandeling urotheelcarcinoom met pembrolizumab

Read more